Terry Dagnon - Dec 3, 2021 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Chief Operating Officer
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Stock symbol
OTLK
Transactions as of
Dec 3, 2021
Transactions value $
$14,200
Form type
4
Date filed
12/3/2021, 03:32 PM
Next filing
Dec 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Purchase $14.2K +10K +0.89% $1.42 1.14M Dec 3, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.